Telesta's Bladder Cancer Therapy To Face Questions On Evidence Adequacy
This article was originally published in The Pink Sheet Daily
Executive Summary
Canadian firm will try to persuade two FDA advisory committees that 129-patient, single-arm, Phase III study supports approval of MCNA for non-muscle invasive bladder cancer.